Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dermot P B McGovern

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
Expert Review of Clinical Immunology|March 7, 2012
LRRK2 as a negative regulator of NFAT: implications for the pathogenesis of inflammatory bowel diseasePuja Vora, Dermot P B McGovern
Expert Review of Clinical Immunology|May 10, 2016
Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utilityByong Duk Ye, Dermot P B McGovern
Nature Reviews. Gastroenterology & Hepatology|December 19, 2013
Towards personalized care in IBDMark E Gerich, Dermot P B McGovern
Gastroenterology|October 13, 2016
Paneth Cell Alterations in the Development and Phenotype of Crohn's DiseaseThaddeus S Stappenbeck, Dermot P B McGovern
Inflammatory Bowel Diseases|May 4, 2005
NOD2, not yet: conSteven R Brant, Dermot P B McGovern
Inflammatory Bowel Diseases|June 22, 2022
Medical and Surgical Implications of Mesenteric Adipose Tissue in Crohn's Disease: A Review of the LiteraturePhillip Gu, Shishir Dube, Dermot P B McGovern
Scientific Reports|February 26, 2026
Imputation methods for serologic biomarkers in inflammatory bowel diseaseMiad Boodaghidizaji, Dermot P B McGovern, Dalin Li
European Journal of Gastroenterology & Hepatology|March 1, 2003
Thiopurine therapy: when to start and when to stopDermot P B McGovern, Simon P L Travis
Gastroenterology|August 11, 2015
Genetics of Inflammatory Bowel DiseasesDermot P B McGovern, Subra Kugathasan, Judy H Cho
The New England Journal of Medicine|March 11, 2026
Genetic Variation in Clinical CohortsLauren V Collen, Dermot P B McGovern, Scott B Snapper
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
Expert Review of Clinical Immunology|March 7, 2012
LRRK2 as a negative regulator of NFAT: implications for the pathogenesis of inflammatory bowel diseasePuja Vora, Dermot P B McGovern
Expert Review of Clinical Immunology|May 10, 2016
Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utilityByong Duk Ye, Dermot P B McGovern
Nature Reviews. Gastroenterology & Hepatology|December 19, 2013
Towards personalized care in IBDMark E Gerich, Dermot P B McGovern
Gastroenterology|October 13, 2016
Paneth Cell Alterations in the Development and Phenotype of Crohn's DiseaseThaddeus S Stappenbeck, Dermot P B McGovern
Inflammatory Bowel Diseases|May 4, 2005
NOD2, not yet: conSteven R Brant, Dermot P B McGovern
Inflammatory Bowel Diseases|June 22, 2022
Medical and Surgical Implications of Mesenteric Adipose Tissue in Crohn's Disease: A Review of the LiteraturePhillip Gu, Shishir Dube, Dermot P B McGovern
Scientific Reports|February 26, 2026
Imputation methods for serologic biomarkers in inflammatory bowel diseaseMiad Boodaghidizaji, Dermot P B McGovern, Dalin Li
European Journal of Gastroenterology & Hepatology|March 1, 2003
Thiopurine therapy: when to start and when to stopDermot P B McGovern, Simon P L Travis
Gastroenterology|August 11, 2015
Genetics of Inflammatory Bowel DiseasesDermot P B McGovern, Subra Kugathasan, Judy H Cho
The New England Journal of Medicine|March 11, 2026
Genetic Variation in Clinical CohortsLauren V Collen, Dermot P B McGovern, Scott B Snapper
Pageof 21